121 related articles for article (PubMed ID: 11425670)
1. Shaken not stirred.
Sebag J
Ophthalmology; 2001 Jul; 108(7):1177-8. PubMed ID: 11425670
[No Abstract] [Full Text] [Related]
2. Adjuvant 5-fluorouracil and heparin prevents proliferative vitreoretinopathy : Results from a randomized, double-blind, controlled clinical trial.
Asaria RH; Kon CH; Bunce C; Charteris DG; Wong D; Khaw PT; Aylward GW
Ophthalmology; 2001 Jul; 108(7):1179-83. PubMed ID: 11425671
[TBL] [Abstract][Full Text] [Related]
3. Retinal detachment repair by vitrectomy: simplified formulae to estimate the risk of failure.
Wickham L; Bunce C; Wong D; Charteris DG
Br J Ophthalmol; 2011 Sep; 95(9):1239-44. PubMed ID: 21325394
[TBL] [Abstract][Full Text] [Related]
4. A randomized controlled trial of combined 5-fluorouracil and low-molecular-weight heparin in management of established proliferative vitreoretinopathy.
Charteris DG; Aylward GW; Wong D; Groenewald C; Asaria RH; Bunce C;
Ophthalmology; 2004 Dec; 111(12):2240-5. PubMed ID: 15582080
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant 5-FU and heparin prevent PVR.
Allinson RW
Ophthalmology; 2002 May; 109(5):829-30; author reply 830. PubMed ID: 11986080
[No Abstract] [Full Text] [Related]
6. Prophylactic intravitreal 5-fluorouracil and heparin to prevent proliferative vitreoretinopathy in high-risk patients with retinal detachment: study protocol for a randomized controlled trial.
Schaub F; Hoerster R; Schiller P; Felsch M; Kraus D; Zarrouk M; Kirchhof B; Fauser S
Trials; 2018 Jul; 19(1):384. PubMed ID: 30012187
[TBL] [Abstract][Full Text] [Related]
7. Giant Proliferative Membrane Triggering Re-retinal Detachment after Vitrectomy.
Eguchi M; Sakaguchi H; Nishida K
Ophthalmol Retina; 2021 Jul; 5(7):655. PubMed ID: 34243969
[No Abstract] [Full Text] [Related]
8. Intravitreal low molecular weight heparin and 5-Fluorouracil for the prevention of proliferative vitreoretinopathy following retinal reattachment surgery.
Sundaram V; Barsam A; Virgili G
Cochrane Database Syst Rev; 2010 Jul; (7):CD006421. PubMed ID: 20614445
[TBL] [Abstract][Full Text] [Related]
9. [Prevention of proliferative vitreoretinopathy using 5-FU heparin: clinical tolerance and efficacy].
Scheer S; Morel C; Poisson F; Bonnel S; Touzeau O; Sahel JA; Laroche L
J Fr Ophtalmol; 2005 Sep; 28(7):701-6. PubMed ID: 16208219
[TBL] [Abstract][Full Text] [Related]
10. Surgical failure following primary retinal detachment surgery by vitrectomy: risk factors and functional outcomes.
Wickham L; Ho-Yen GO; Bunce C; Wong D; Charteris DG
Br J Ophthalmol; 2011 Sep; 95(9):1234-8. PubMed ID: 21156702
[TBL] [Abstract][Full Text] [Related]
11. [Surgical treatment of rhegmatogenous retinal detachments with high risk of proliferative vitreoretinopathy].
Akhundova LA; Kasimov EM
Vestn Oftalmol; 2017; 133(3):51-57. PubMed ID: 28745657
[TBL] [Abstract][Full Text] [Related]
12. [Proliferative vitreoretinopathy].
Toma C
Oftalmologia; 2004; 48(3):6-10. PubMed ID: 15598042
[TBL] [Abstract][Full Text] [Related]
13. PVR as a complication of rhegmatogeneous retinal detachment: a solved problem?
Joeres S; Kirchhof B; Joussen AM
Br J Ophthalmol; 2006 Jun; 90(6):796-7. PubMed ID: 16714271
[No Abstract] [Full Text] [Related]
14. Patomechanisms in proliferative vitreoretinopathy.
Kaczmarek R; Misiuk-Hojło M
Klin Oczna; 2011; 113(1-3):64-7. PubMed ID: 21853955
[TBL] [Abstract][Full Text] [Related]
15. Systemic resorption of 5-fluorouracil used in infusion fluid during vitrectomy.
Creten O; Spileers W; Stalmans P
Bull Soc Belge Ophtalmol; 2007; (303):37-41. PubMed ID: 17894285
[TBL] [Abstract][Full Text] [Related]
16. [Proliferative Vitreoretinopathy].
Wiedemann P; Bringmann A
Klin Monbl Augenheilkd; 2016 Sep; 233(9):1012-5. PubMed ID: 27479581
[TBL] [Abstract][Full Text] [Related]
17. Re: Schaub et al.: Intravitreal 5-fluorouracil and heparin to prevent proliferative vitreoretinopathy: results from a randomized clinical trial (Ophthalmology. 2022;129:1129-1141).
van Overdam KA; Sebag J
Ophthalmology; 2023 Jun; 130(6):e21. PubMed ID: 37210149
[No Abstract] [Full Text] [Related]
18. [Possible role of alkylphosphocholines in retinal reattachment surgery].
Eibl KH; Lewis GP; Betts K; Linberg KA; Gandorfer A; Fisher SK; Kampik A
Ophthalmologe; 2007 Nov; 104(11):972-7. PubMed ID: 17899122
[TBL] [Abstract][Full Text] [Related]
19. External validation of existing formulas to predict the risk of developing proliferative vitreoretinopathy: the Retina 1 Project; report 5.
Sala-Puigdollers A; Fernández I; Coco RM; Sanabria MR; Rodríguez de la Rúa E; Ruiz-Moreno JM; Navea A; Suárez de Figueroa M; Pastor JC
Retina; 2013 Sep; 33(8):1519-27. PubMed ID: 23594721
[TBL] [Abstract][Full Text] [Related]
20. Randomized controlled trial of combined 5-Fluorouracil and low-molecular-weight heparin in the management of unselected rhegmatogenous retinal detachments undergoing primary vitrectomy.
Wickham L; Bunce C; Wong D; McGurn D; Charteris DG
Ophthalmology; 2007 Apr; 114(4):698-704. PubMed ID: 17398320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
